Samantha M. Hall

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

J. Greenbaum, Bjoern Peters, S. Schoenberger, 2023, bioRxiv.

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.

J. Greenbaum, Bjoern Peters, S. Schoenberger, 2023, The Journal of clinical investigation.